Switching From Humira To Enbrel For Arthritis Treatment
The U.S. Food and Drug Administration (FDA) has begun a safety review of tumor necrosis factor (TNF) blockers, a class of drugs that includes the medications Enbrel, Remicade, and Humira. The agency says the drugs are being reviewed for a possible link with the development of lymphoma and other cancers in children and young adults treated for juvenile idiopathic arthritis and Crohn's disease. While the review is ongoing, the FDA is advising doctors to weigh the possible cancer link against the...
Read moreMore information on "Switching From Humira To Enbrel For Arthritis Treatment"
From Our Experts
FDA reviewing Humira, Remicade and Enbrel for cancer risk
According to a notice published today on the Food and Drug Administration website, FDA is investigating the possible association between... Read more »
When is it OK to Switch Rheumatoid Arthritis Medications?
Rheumatoid arthritis is a chronic inflammatory disorder that has no cure. It is an autoimmune disorder, in which the patient’s own... Read more »
Rheumatoid Arthritis: New Therapies and Higher Costs
Rheumatoid arthritis is a chronic and progressive illness which has a large impact on those afflicted. The destruction of joints can... Read more »
What is the "Best" Rheumatoid Arthritis Treatment?
I am often asked what treatment or combination of treatments should be used in rheumatoid arthritis. The honest answer is that there is,... Read more »
A New Drug for Rheumatoid Arthritis in 2008?
The American College of Rheumatology Annual Scientific Meeting in Boston last week provided more good data on the new-and... Read more »
From Our Sources
Study: RA drugs like Enbrel, Humira do not raise cancer risk
There's good news for rheumatoid arthritis (RA) patients who use tumor necrosis factor (TNF) blockers like Humira, Remicide, and Enbrel. Researchers... Read more »
Study May Explain Why Humira Fails Some with Rheumatoid Arthri...
Results from a new study may shed light on why many people who take the rheumatoid arthritis (RA) biologic drug Humira (adalimumab) do not respond to... Read more »
Humira approved for treating psoriatic arthritis joint damage
The Food and Drug Administration has approved Humira for a new use. Humira may now be used to slow joint damage in people with psoriatic arthritis.... Read more »
Study: Less Enbrel needed to control RA
British researchers say rheumatoid arthritis (RA) patients treated with Enbrel need fewer dose escalations in their first year of treatment than... Read more »
Enbrel safe for children with RA: study
Drugmaker Wyeth has announced that a three-year study has found that Enbrel is a safe and effective treatment for children with the juvenile form of... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
